On 6 May 2022, the Food Standard for Australia and New Zealand (FSANZ) issued Notice 199-22 approving application A1233 to allow the use of 2' -fucose lactose (2'-FL) derived from escherichia coli K-12 in infant formula food.  The maximum dosage is 2.4 g/L (i.e., powder or liquid form) and the label of products with 2'-FL added prohibits the use of "breast-milk identical oligosaccharides" or "breast-milk oligosaccharides" as well as "HMO", "HiMO" or any term or abbreviation with the same or similar meaning. 

The notice will come into effect after the publication of the Anz Food Codex.